From mint · · 1m 10s
Heineken warns UK pubs: Weight-loss drugs could hit beer sales
Heineken urges UK pubs to adapt as weight-loss drugs reduce beer sales.
In brief
Heineken urges UK pubs to adapt as weight-loss drugs reduce beer sales. Heineken warns UK pubs that GLP-1 weight-loss drugs could cut beer sales by 7% as users opt for smaller drinks. Originally reported by mint.
Heineken warns UK pubs
Heineken urges British pubs to adapt to weight-loss drugs or risk losing customers and revenue.
“Heineken Warns Pubs to Adapt as Weight-Loss Drugs Curb Drinking”
GLP-1 use surges
JPMorgan research shows 10 million US users took weight-loss drugs like Ozempic and Wegovy last year.
GLP-1 impacts drinking
GLP-1 users reduced alcohol spending by 7% monthly compared to non-users after two years on the drugs.
Heineken's advice
Heineken advises pubs to promote half-pints, low-alcohol drinks, and pair with small plates to retain customers.
Beer sales in UK
Beer sales in UK pubs generated £14 billion annually with less than £300 million from low-alcohol beers.
GLP-1 users cut drinking
Ten of 11 GLP-1 users surveyed said they reduced drinking significantly due to discomfort or loss of desire.
Heineken's stance
Heineken says GLP-1 users are shifting to smaller serves and premium products but beer sales may decline.
The essence
Heineken warns UK pubs that GLP-1 weight-loss drugs could cut beer sales by 7% as users opt for smaller drinks.
